Back to search

Ireland· IE-PA-EU/1/09/514/024

Zebinix 50 mg/ml Oral suspension

A eslicarbazepine product containing eslicarbazepine acetate, registered in Ireland by BIAL-Portela & Ca, S.A.. The same ATC class is registered in 16 of our 19 countries.

ATC N03AF04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedZebinix 50 mg/ml Oral suspensionATCN03AF04REGISTER NO.IE-PA-EU/1/09/514/024PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Eslicarbazepine is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AF04 (eslicarbazepine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 10 of them publish a price we can compare per daily dose

Eslicarbazepine · ATC N03AF04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eslicarbazepine costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $2.32 in Italy to $4.08 in Switzerland — a ×1.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Eslicarbazepine · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.08
  • ES Spain$3.49
  • IT Italy$2.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Eslicarbazepine acetate
Manufacturer
BIAL-Portela & Ca, S.A.
Country
Ireland (IE)
ATC code
N03AF04
ATC class
Eslicarbazepine
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/09/514/024

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

188 interactions on record for eslicarbazepine.

Graded by severity as the source publishes them — 17 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eslicarbazepine · interactions on record

188 records

  • 17 severe
  • 166 moderate
  • 5 minor

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eslicarbazepine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eslicarbazepine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Eslibon
  • Bulgaria · Еслибон
  • Cyprus · Esran
  • Czechia · Eslibon, Eslikarbazepin Neuraxpharm
  • Germany · Eslibon, Eslicarbazepin Al
  • Denmark · Arupsan, Eslicarbazepinacetat "stada"
  • Spain · Arupsan, Bixcar
  • France · Eslicarbazepine 800, Eslicarbazepine Arrow
  • United Kingdom (Northern Ireland) · Arupsan, Eslicarbazepine Amarox
  • Greece · Esran
  • Hungary · Eslicarbazepine 800
  • Iceland · Eslicarbazepin, Eslicarbazepine Acetate Stada
  • Italy · Arupsan, Eslicarbazepina Acetato Aurobindo
  • Liechtenstein · Zebinix
  • Malta · Esran
  • Netherlands · Eslibon
  • Norway · Zebinix
  • Poland · Eslibon
  • Portugal · Acetato De Eslicarbazepina Alter, Acetato De Eslicarbazepina Aristo
  • Sweden · Arupsan
  • Slovakia · Eslibon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/66cdf31c-f732-4e95-9557-b2b9282a1b0d
GET /v1/drugs/66cdf31c-f732-4e95-9557-b2b9282a1b0d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral suspension",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N03AF",
    "N03AF04"
  ],
  "strength": null,
  "pa_number": "EU/1/09/514/024",
  "substances": [
    "Eslicarbazepine acetate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "08/12/2016",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about eslicarbazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.